CEI Podcast for June 29, 2011: Stealing You Blind

 

Have a listen here.

Vice President for Strategy Iain Murray‘s new book is Stealing You Blind: How Government Fat Cats Are Getting Rich Off of You. He explains why the Washington, DC area is the richest in the country, tells the story of the small-town city manager with a tax-free $1 million-per-year pension, and offers some reforms that could bring government down to a more appropriate size.

Economic Freedom

There is a small bit of hyperbole at the end. But aside from that, this is a really good video that explains just how much better off people are in free economies than their unfree variants — especially the poor.

Regulation Roundup

With the unemployment rate still over 9 percent, regulators have been very busy tending to their own job security. Here are some of their more recent make-work programs:

-In King County, Washington, swimming without a life vest is punishable by an $86 fine.

-New food regulations in New York would make it illegal to cut cheese in farmer’s markets.

-A new California regulation would require retailers to provide seating for cashiers.

-The Consumer Product Safety Commission adopted voluntary new standards for cribs in 2008. Now it has decided to make them both mandatory and retroactive. That means that roughly 100,000 unsold cribs currently sitting in stores will have to be thrown away. Hopefully smaller retailers can survive the hit.

San Francisco is poised to ban goldfish.

-New EU regulations would require farmers to look after their pigs’ emotional well-being.

A weakened version of Texas’ TSA pat-down ban passed both houses of the state legislature. TSA agents found guilty would face up to a year in jail and a $4,000 fine. The loopholes in this version appear large enough that it would do little to stop the pat-downs. Other states are considering similar measures.

New York Times Profiles Ryan Braun

This week, the Brewers will play a series against the Yankees in New York for the first time since 1997. The New York Times used the occasion to profile Ryan Braun. It’s worth a read; very rarely does a player of his caliber stay with a small-market team for an entire career. Braun signed a contract extension earlier this season to stay in Milwaukee through 2020, when he’ll turn 36. This fan wishes there were more like him.

CEI Podcast for June 23, 2011: Bunker Fuel

 

Have a listen here.

Bunker fuel is  a heavy fuel used by large ships around the world. Oil tankers, container ships, and more rely on bunker fuel because it’s cheaper than other kinds of fuel. Land Use and Transportation Policy Analyst Marc Scribner takes a look at new environmental regulations in California intended to reduce bunker fuel usage. The rules are actually causing many ships to use more bunker fuel, not less. If proposed fixes succeed, the result would essentially be a tariff on most global trade — a $16 trillion industry.

Technology Doesn’t Destroy Jobs

Russ Roberts with a must-read in yesterday’s WSJ:

The story goes that Milton Friedman was once taken to see a massive government project somewhere in Asia. Thousands of workers using shovels were building a canal. Friedman was puzzled. Why weren’t there any excavators or any mechanized earth-moving equipment? A government official explained that using shovels created more jobs. Friedman’s response: “Then why not use spoons instead of shovels?”

Read the whole thing.

We Need Regulators, Not Interveners

The Constitution’s Commerce Clause gives Congress the power to regulate commerce. What does that mean, exactly? Over at the Daily Caller, my colleague Jacque Otto and I explain that regulation is about making commerce regular: no barriers to entry or trade, clear, understandable, and consistent rules, and so on.

Most of what people call regulation doesn’t have anything to with regular commerce. These kinds of rules are more accurately called interventions.

These interventions didn’t appear out of thin air, either:

One important reason regulators intervene is that many businesses want them to — businesses spend considerable effort and resources lobbying Washington to that end. For the most part, American companies compete on quality, price, or other consumer preferences. But on too many occasions, some companies try to use regulatory interventions to dispatch the competition. Sprint’s efforts to squander AT&T’s proposed purchase of T-Mobile are emblematic of this troubling trend.

Lessons abound for antitrust regulators — sorry, interveners.

Where Do TSA-Confiscated Items Go?

The TSA has a habit of confiscating security-unrelated items. Over at The American Spectator, I recall just such an experience that I had at O’Hare. After years of wondering what became of my beloved Leatherman, I was able to find a likely answer: it probably found its way to a government surplus store. One store alone made $300,000 just from TSA-confiscated items. As I conclude:

So rest easy the next time a TSA screener takes away your spear gun (yes, that’s on the verboten list). You’re not just making air travel safer by leaving it behind. You’re also doing your part to reduce government deficits.

TSA policies are an over-reaction to a rare threat that kills fewer people each year than lightning strikes. Unfortunately, the human mind is not entirely rational when calculating the risk from rare but conspicuous threats, so the TSA is probably here to stay.

No Such Thing as an Average Cancer Patient

My colleague Greg Conko has an excellent piece in today’s Wall Street Journal. Greg doesn’t think it’s right that the FDA is denying terminally ill patients access to potentially life-saving treatments.

The latest case in point is a drug called Avastin. It is approved for treating several types of cancer. But the FDA is moving to revoke its approval for treating breast cancer. This has, understandably, upset many breast cancer patients and their doctors.

The heart of the matter is who shall be in charge of treatment decisions. Should it be patients and doctors? Or should the FDA decide for them?

Greg thinks a decentralized approach is better. Different patients will react to the same drug in different ways. A doctor can see if Avastin works or not for a patient, and they can make the right decision from there. The FDA relies on averages and medians for making its approval decisions, ignoring individuals. The trouble with that is, as Greg points out, there is no such thing as an average cancer patient.

A few weeks ago, I interviewed Greg about Avastin and the FDA here.

Beyond Binary Politics

Nick Gillespie and Matt Welch have a must-read essay in today’s Wall Street Journal on the rise of independents, and the decline of the Republican and Democratic parties.

Their main point is that duopolies tend to die out when they abuse their customers. That is exactly what the two parties have been doing; no wonder people have been abandoning them in droves.